BEIJING NEURONBC LABORATORIES CO.,LTD Wraps Up Fruitful CPHI & PMEC China 2026 at Booth W5A60
Shanghai, June 19, 2026 BEIJING NEURONBC LABORATORIES CO.,LTD. (NeuronBC), a seasoned domestic developer and manufacturer of pharmaceutical compliance testing instruments, closed its three-day exhibition at CPHI & PMEC China 2026 last week at Shanghai New International Expo Centre. The firm brought its full lineup of integrity testing, TOC analysis and pharmaceutical lab equipment to Hall W5 Booth A60, drawing consistent traffic from overseas distributors, local pharma manufacturers, QA validation specialists and biotech lab managers across Asia, Europe and Latin America.
Running June 16–18, this year's CPHI China remains Asia's flagship pharmaceutical manufacturing and raw material platform, uniting more than 3,600 exhibitors and over 100,000 professional visitors worldwide. For NeuronBC, the show served as a critical face-to-face channel to present its independently engineered testing solutions tailored to global GMP, USP, EP and Chinese Pharmacopoeia compliance standards.
On full display at the booth were the brand's flagship instruments, including the upgraded V8.0 Filter Integrity Tester, TA series TOC Analyzers, osmometers, packaging leak detectors and liquid particle counters. Every unit features built-in audit trails, full data traceability and automated test workflows, designed to cut validation workloads for sterile production lines, water systems and quality control labs. The water-based test function on the integrity tester stood out to many international guests, as it eliminates reliance on flammable organic solvents and lowers routine operational costs for pharmaceutical filtration workflows.
The company's technical and overseas sales team held one-on-one consultations throughout the event, walking visitors through real-world validation cases for sterile filtration, water system monitoring and finished drug inspection. Many overseas partners expressed strong interest in regional distribution cooperation, with multiple preliminary framework agreements reached for markets in South Korea, Brazil, Chile and Southeast Asia.
"We value CPHI China as our most important annual platform to connect with global industry players," said the head of NeuronBC's international division. "Over the three days, we received practical feedback on regional regulatory demands, which will guide our product iteration and localized service support for overseas clients. As more global pharma teams source reliable, cost-effective testing equipment from China, we aim to deliver stable, fully compliant instruments paired with consistent after-sales technical support."
Beyond hardware displays, NeuronBC also shared its complete validation service packages, covering IQ/OQ documentation, on-site instrument calibration and regulatory consultation to help clients simplify factory audit preparations. The firm's emphasis on full lifecycle technical support resonated heavily with mid-sized biopharma firms and contract manufacturers looking to streamline their quality systems.
This exhibition marks another milestone in NeuronBC's ongoing global expansion. The team will follow up with all booth visitors in the coming weeks to finalize technical quotations and distribution cooperation plans, while continuing to upgrade its product range to match tightening international pharmaceutical regulatory requirements.
